IL17A and breast cancer: Our study proposes a novel mechanism by which it could contribute to BC progression due to interactions between mesenchymal stem cells from obese adipose tissue (ob-ASC) with infiltrating immune cells and the promotion of pathogenic cells double-secreting IL-17/IFNγ.